immunologist
approach
end
train
mani
face
question
next
career
step
mani
research
seek
career
insid
academia
pharmaceut
biotechnolog
industri
other
attract
altern
pursu
scientif
career
govern
institut
career
govern
agenc
highli
regard
offer
interest
array
stabl
job
opportun
immunologist
work
effect
divers
rang
public
health
issu
commentari
focus
particularli
three
institut
long
histori
discoveri
innov
safeguard
advanc
public
health
us
nation
institut
health
nih
us
food
drug
administr
fda
center
diseas
control
prevent
cdc
nih
nih
world
largest
biomed
research
institut
fund
agenc
http
wwwnihgovabout
compos
institut
center
scientif
agenda
focus
specif
diseas
andor
biolog
system
immunologist
pursu
scientif
career
vast
major
nih
budget
goe
extramur
research
commun
fund
research
academ
privat
institut
locat
unit
state
around
world
competit
remain
nih
budget
support
research
intramur
laboratori
sever
locat
usa
global
world
diseas
tuberculosi
malaria
hivaid
emerg
infecti
diseas
cancer
autoimmun
allergi
rare
undiagnos
diseas
institut
center
hous
continuum
biomed
research
rang
basic
research
translat
research
treatment
prevent
nih
long
tradit
immunolog
infecti
diseas
date
creation
laboratori
hygien
staten
island
driven
grow
need
research
immunolog
nih
grown
aspect
immunolog
research
nih
earli
reflect
fascin
chapter
william
e
paul
thoma
waldmann
nih
account
research
laboratori
today
main
campu
bethesda
maryland
locat
countri
nih
intramur
research
program
host
one
largest
product
immunolog
commun
world
laboratori
distribut
variou
institut
http
irpnihgovourresearchscientificfocusareasimmunolog
among
mani
semin
discoveri
nih
immunologist
clone
cell
antigen
receptor
discoveri
interleukin
well
chain
receptor
elucid
threedimension
structur
antibodi
codiscoveri
caus
agent
hivaid
extraordinari
assemblag
research
clinician
includ
world
leader
immunolog
field
nurtur
develop
new
gener
immunologist
phd
andor
md
nih
stateoftheart
laboratori
clinic
center
facil
immunologist
across
nih
share
membership
immunolog
interest
group
current
member
group
promot
interact
insid
outsid
commun
scientif
activ
weekli
lectur
seri
anoth
import
activ
yearli
workshop
twoday
symposium
gather
nih
immunologist
larg
intramur
program
workshop
commun
seen
action
senior
investig
provid
oneonon
feedback
traine
present
research
work
engag
excit
discuss
one
central
topic
immunolog
nih
intramur
immunolog
commun
also
crossfertil
group
nci
center
excel
immunolog
transnih
center
human
immunolog
translat
immunolog
section
nation
institut
arthriti
musculoskelet
skin
diseas
stabl
fund
provid
intramur
research
program
nih
allow
scientist
basic
clinic
research
enjoy
freedom
pursu
new
interest
engag
innov
highrisk
highreward
research
project
interest
follow
benchscientist
career
tenuretracktenur
elig
investig
nih
offer
excel
opportun
outstand
young
research
transnih
stadtman
tenuretrack
investig
posit
laboratorybas
research
well
lasker
clinic
research
scholar
program
clinic
investig
nih
also
issu
earli
independ
scientist
award
support
particularli
talent
recent
doctor
graduat
independ
posit
without
requir
postdoctor
train
avail
resourc
remark
divers
research
environ
also
attract
senior
recruit
orient
foster
initi
new
specif
program
basic
clinic
laboratori
intramur
research
program
staff
scientist
phd
staff
clinician
md
posit
outstand
research
work
close
partnership
senior
investig
tenuretracktenur
elig
investig
support
research
program
longterm
posit
wide
rang
function
respons
independ
work
bench
lead
basic
clinic
research
team
develop
new
research
program
manag
core
facil
case
posit
staff
scientist
staff
clinician
evolv
tenuretrack
investigatorship
set
basic
scientist
work
close
proxim
clinic
immunologist
physician
dentist
doctorallevel
research
nih
clinic
center
largest
clinic
research
hospit
us
quot
alan
sher
chief
laboratori
parasit
diseas
nation
institut
allergi
infecti
diseas
close
highli
enthusiast
interact
basic
scientist
clinic
research
make
nih
uniqu
place
work
human
diseas
environ
bedsidetobench
benchtobedsid
research
program
strongli
encourag
nih
clinic
center
multidisciplinari
team
research
form
basic
clinic
immunologist
specialti
work
togeth
ultim
goal
understand
human
diseas
develop
new
treatment
translat
discoveri
intramur
laboratori
clinic
protocol
determin
effect
human
diseas
addit
translat
clinic
vaccin
immunotherapi
cancer
autoimmun
infecti
diseas
among
other
nih
support
research
program
fill
gap
knowledg
help
promot
rapid
translat
new
treatment
option
patient
suffer
rare
undiagnos
diseas
dynam
partnership
basic
research
clinic
research
work
togeth
understand
human
diseas
distinct
featur
work
experi
nih
essenc
captur
h
clifford
lane
director
divis
clinic
research
nation
institut
allergi
infecti
diseas
mention
year
nihclin
center
provid
place
rapid
translat
bench
research
clinic
investig
also
noteworthi
abil
rapidli
adapt
new
challeng
hivaid
sar
recent
ebola
intramur
research
program
nih
foster
intern
research
program
around
world
diseaseendem
countri
address
critic
global
health
issu
promot
sustain
partnership
build
infrastructur
scientif
capac
initi
encourag
exchang
scientif
knowledg
research
provid
train
opportun
strength
biomed
research
capac
host
countri
basic
clinic
immunologist
nih
work
multicultur
environ
make
import
contribut
address
global
heath
challeng
addit
research
career
opportun
program
provid
career
track
immunologist
interest
global
health
scienc
polici
nih
play
critic
role
scientif
commun
fund
immunolog
research
unit
state
around
world
institut
extramur
program
consist
immunologist
md
andor
phd
serv
scientif
review
offic
program
director
program
offer
anoth
remark
career
opportun
outstand
experienc
immunologist
interest
develop
career
area
posit
requir
sophist
knowledg
research
continu
understand
advanc
field
immunolog
ricardo
cibotti
program
director
nation
institut
arthriti
musculoskelet
skin
diseas
said
reward
aspect
nih
extramur
program
director
job
includ
interact
new
investig
plan
research
project
submiss
nih
promot
advoc
best
scienc
help
gener
promis
initi
acceler
discoveri
develop
basic
clinic
research
overal
mani
excit
career
opportun
biomed
research
medicin
scienc
polici
regulatori
affair
area
nih
offer
given
nih
uniqu
attract
institut
young
scientist
establish
career
immunolog
fda
fda
provid
divers
array
opportun
outstand
welltrain
scientist
want
clear
direct
effect
public
health
research
nih
scientist
pursu
career
bench
away
fda
scienc
obvious
focus
mission
http
wwwfdagovaboutfdawhatwedo
fda
respons
protect
public
health
assur
safeti
efficaci
secur
human
veterinari
drug
biolog
product
medic
devic
nation
food
suppli
cosmet
product
emit
radiat
fda
also
respons
advanc
public
health
help
speed
innov
make
medicin
effect
safer
afford
help
public
get
accur
sciencebas
inform
need
use
medicin
food
maintain
improv
health
opportun
work
public
health
environ
make
differ
patient
societi
scientist
highlight
discuss
experi
word
sue
epstein
associ
director
research
center
biolog
evalu
research
come
age
heyday
civil
right
movement
includ
five
year
live
south
side
chicago
want
work
social
relev
field
one
could
benefit
peopl
walk
life
lead
immunolog
research
program
review
product
applic
particip
licens
review
inspect
develop
regulatori
polici
dawn
field
gene
therapi
cell
therapi
particip
meet
influenza
control
immunologist
choos
leav
activ
bench
scienc
take
posit
review
product
chemistri
manufactur
expect
part
multidisciplinari
team
includ
clinician
chemist
microbiologist
toxicologist
clinic
pharmacologist
chemic
engin
team
work
togeth
regul
variou
aspect
product
start
first
studi
human
test
clinic
safeti
licens
process
postmarket
stage
also
opportun
focu
surveil
system
detect
postmarket
safeti
laps
well
manufactur
complianc
issu
requir
applic
scientif
knowledg
tie
product
qualiti
issu
product
safeti
efficaci
pursu
issu
polici
want
career
research
import
featur
distinguish
fda
scientist
conduct
research
parallel
regulatori
review
duti
direct
contact
team
review
product
clinic
develop
thu
uniqu
posit
understand
challeng
limit
clinic
develop
regul
therapeut
product
accordingli
research
project
gear
toward
acquisit
critic
knowledg
area
facilit
develop
novel
regulatori
paradigm
provid
scientif
support
develop
applic
new
regulatori
polici
decisionmak
undertak
dual
role
researcherreview
challeng
handson
expertis
bioanalyt
method
silico
vitro
well
anim
model
use
improv
product
character
provid
review
knowledg
understand
product
regul
convers
firsthand
experi
regulatori
submiss
allow
research
formul
question
address
scientif
gap
need
fill
support
regulatori
decisionmak
lab
locat
brand
new
stateoftheart
laboratori
complex
furnish
key
core
facil
fda
immunologist
perform
cuttingedg
studi
almost
everi
field
immunolog
includ
adjuv
immunomodul
immunotoler
stem
cell
biolog
inflamm
cancer
therapeut
autoimmun
infecti
diseas
well
strong
program
vaccin
develop
exampl
innat
immun
laboratori
use
varieti
vitro
vivo
model
studi
immunomodulatori
effect
agonist
innat
immun
system
variou
tissu
inform
evalu
new
vaccin
adjuv
cancer
therapi
molecul
develop
trigger
shape
desir
immun
respons
also
field
therapeut
protein
biosimilar
immun
respons
dramat
consequ
inde
improv
understand
immunomodulatori
effect
innat
immunomodul
impur
help
industri
improv
qualiti
product
allow
fda
make
critic
decis
licens
first
vaccin
adjuv
design
activ
tolllik
receptor
approv
new
gener
version
complex
molecul
lowmolecularweight
heparin
broaden
access
import
fund
laboratori
provid
via
combin
fund
us
govern
fraction
fee
paid
industri
review
product
distribut
via
system
intramur
project
grant
stabl
fund
allow
scientist
freedom
develop
highli
innov
program
across
disciplin
undertak
challeng
scientif
question
inform
regul
exist
develop
product
young
immunologist
find
fda
one
strongest
profession
develop
program
span
myriad
regulatori
basic
scienc
issu
scientist
frequent
particip
togeth
nih
group
immunolog
interest
group
glycobiolog
interest
group
cytokin
interest
group
virolog
interest
group
foster
interact
collabor
practic
effect
strong
research
program
fda
clear
allow
fda
keep
rapidli
evolv
manufactur
bioanalyt
character
technolog
understand
mechan
action
groundbreak
product
forese
potenti
safeti
risk
manner
fda
face
new
challeng
whether
take
form
new
therapeut
emerg
pathogen
novel
deliveri
system
biosimilar
intellig
devic
without
excess
timid
would
delay
innov
exampl
immunologist
fda
focus
factor
determin
immunogen
therapeut
protein
replac
enzym
blood
factor
immun
respons
product
negat
effect
even
result
develop
autoimmun
diseas
patient
improv
understand
factor
involv
protein
immunogen
led
industri
improv
bioanalyt
character
clinic
monitor
well
develop
toler
regimen
indic
togeth
result
improv
therapeut
efficaci
product
safeti
thorough
understand
basic
scienc
current
technolog
patient
need
well
challeng
exist
therapi
push
scientist
fda
advoc
concept
gener
new
improv
version
exist
biolog
agent
would
benefit
patient
diminish
advers
outcom
mani
diseas
might
reduc
health
care
cost
thu
work
fda
often
provid
scientist
tangibl
sens
effect
develop
new
vaccin
therapi
unmet
medic
need
cindi
buhs
director
offic
test
research
said
work
year
industri
reduc
back
order
stock
holder
valu
sale
figur
motiv
fda
mission
public
health
make
come
work
excit
cdc
cdc
healthprotect
agenc
usa
mission
protect
usa
threat
health
safeti
secur
domest
foreign
role
detect
respond
new
emerg
health
threat
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
influenza
viru
pandem
anthrax
hivaid
ebola
viru
put
scienc
technolog
action
prevent
diseas
develop
train
public
health
leader
contribut
global
health
secur
excit
place
work
research
interest
direct
effect
public
health
cdc
main
campu
locat
atlanta
georgia
major
laboratori
locat
howev
laboratori
locat
cdc
facil
around
countri
includ
fort
collin
colorado
puerto
rico
alaska
cincinnati
ohio
although
cdc
laboratori
focus
infecti
diseas
also
opportun
environment
health
newbornscreen
program
infecti
diseas
laboratori
hous
four
center
differ
focu
mission
nation
center
immun
respiratori
diseas
nation
center
emerg
zoonot
infecti
diseas
nation
center
hivaid
viral
hepat
sexual
transmit
diseas
tuberculosi
prevent
center
global
health
laboratori
center
gener
dedic
specif
organ
immunologist
wish
pursu
career
bench
find
excit
rang
opportun
infecti
diseas
immunolog
rang
cuttingedg
pathogenesi
studi
novel
assay
develop
clinic
trial
support
fellowship
opportun
newli
mint
phd
postdoctor
fellow
offer
discret
program
american
societi
microbiolog
fellowship
program
usual
hire
mechan
http
wwwusajobsgov
cdc
imposs
absorb
basic
principl
public
health
epidemiolog
bread
butter
cdc
laboratori
diagnost
essenti
investig
outbreak
diseas
surveil
global
set
domest
set
vaccin
research
anoth
area
immunologist
may
find
nich
whether
quest
univers
vaccin
influenza
viru
evalu
novel
adjuv
develop
assay
monitor
immun
respons
novel
vaccin
clinic
trial
local
academ
partner
provid
excel
opportun
collabor
cuttingedg
basic
research
laboratori
cdc
also
collabor
provid
support
state
public
health
lab
network
laboratori
around
world
mani
cdc
laboratori
serv
collabor
center
world
health
organ
http
wwwpepfargov
http
wwwwhointcollaboratingcentresen
epidem
intellig
servic
highlysoughtaft
train
program
interest
combin
specif
skill
formal
train
epidemiolog
http
wwwusajobsgov
http
wwwcdcgovei
posit
part
us
public
health
servic
commiss
corp
uniform
servic
note
everyon
cdc
staff
whether
member
corp
access
prepared
train
cdc
may
serv
emerg
oper
center
activ
respons
emerg
earthquak
haiti
influenza
viru
pandem
ongo
ebola
viru
crisi
west
africa
want
forg
path
away
laboratori
opportun
laboratori
scienc
manag
includ
scienc
polici
biosafeti
biosecur
issu
technolog
transfer
laboratori
scienc
manag
essenti
function
becom
visibl
higher
level
center
mani
public
health
problem
tackl
us
govern
never
dull
day
conclud
remark
government
agenc
describ
nih
fda
immunologist
wide
spectrum
stabl
career
path
agenc
immunologist
appli
knowledg
expertis
help
solv
public
health
issu
whether
research
pursu
benchdriven
career
abil
appli
skill
broader
area
highli
collabor
multidisciplinari
characterist
institut
allow
explor
insid
across
agenc
area
work
enrich
research
experi
contribut
career
develop
growth
